Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients

Systemic inflammation and hypercoagulopathy are known pathophysiological processes of coronavirus disease 2019 (COVID-19), particularly in patients with known cardiovascular disease or its risk factors (CVD). However, whether a cumulative assessment of these biomarkers at admission could contribute...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitakata, Hiroki, Kohsaka, Shun, Kuroda, Shunsuke, Nomura, Akihiro, Kitai, Takeshi, Yonetsu, Taishi, Torii, Sho, Matsue, Yuya, Matsumoto, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304719/
https://www.ncbi.nlm.nih.gov/pubmed/34300252
http://dx.doi.org/10.3390/jcm10143086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304719/
https://www.ncbi.nlm.nih.gov/pubmed/34300252
http://dx.doi.org/10.3390/jcm10143086

Ejemplares similares